Research Briefing | May 6, 2021

US | Recovery Tracker takes a breather as vaccinations slow

recoverytrackeripadfram0705

The US Recovery Tracker fell 0.6ppts to 90.7 in the week ended April 23, its first decline in eight weeks, as three of the six subcomponents fell. This shows that while the recovery is picking up steam, it won’t be without setbacks.

What you will learn:

  • Mobility and demand fell simultaneously as consumers cut back on car trips, flights, dinner nights, and recreation outlays. We believe the end of spring break and the fading boost from stimulus checks are likely culprits for the cooler spending momentum.
  • Health conditions improved as vaccinations increased and fewer new Covid infections were registered. And while inoculations have slowed to an average daily pace of around 2mn from above 3mn in mid-April, we still see the US reaching herd immunity this summer.
  • Increased new business applications and more refinery and steel output drove production higher, while more job postings and lower new jobless claims pushed employment to its best showing since the pandemic began.

Tags: Covid19North AmericaRecovery TrackerUnited States
Back to Resource Hub

Related Services

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

The ruling Liberal Democratic Party's (LDP) landslide election victory on Sunday doesn't change our expectation of a primary fiscal deficit of 2%-3% of GDP in FY2026-FY2028 – we still see the deficit only starting to decline from FY2029. We also keep our view that the 10-year Japanese government bond (JGB) yield will be at 2.3% at end-2026 and 2.5% at end-2027 and beyond.
US and Chinese strength won’t boost all other economies

US and Chinese strength won’t boost all other economies

Upward revisions to US and Chinese GDP growth in Q4 meant that the previously anticipated soft end to 2025 failed to materialise.